EFFECTS OF LOCAL BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH BLADDER-CARCINOMA ON IMMUNOCOMPETENT CELLS OF THE BLADDER WALL

被引:178
作者
BOHLE, A [1 ]
GERDES, J [1 ]
ULMER, AJ [1 ]
HOFSTETTER, AG [1 ]
FLAD, HD [1 ]
机构
[1] BORSTEL RES INST,DEPT IMMUNOL & CELL BIOL,BORSTEL,GERMANY
关键词
D O I
10.1016/S0022-5347(17)39365-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The antitumoral effects of intravesical bacillus Calmette-Guerin against recurrent superficial urothelial bladder cancer seem to be linked to immunological effector mechanisms. To characterize further the local cellular response in the bladder wall of patients receiving intravesical bacillus Calmette-Guerin bladder biopsies were examined before and immediately after a 6-week course of bacillus Calmette-Guerin and for up to 1 year at 3-month intervals thereafter. The results showed a marked infiltration after bacillus Calmette-Guerin therapy predominantly of the suburothelial tissue with mononuclear cells, which expressed activation markers and accumulated to follicle-like granulomatous structures. With regard to T lymphocyte subsets the ratio of T helper-to-T suppressor cells in the bladder wall increased from 0.5 to nearly 2. This phenomenon persisted even in biopsies 1 year after initial treatment. In some probes activated mononuclear cells invaded the urothelium, emanating from suburothelial granulomas. It is tempting to assume that these changes within the local immunocompetent cells are related to the therapeutic effect of bacillus Calmette-Guerin against bladder cancer.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 40 条
[31]  
NISSENKORN I, 1987, EUR UROL, V13, P246
[32]   INTRAVESICAL BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE BLADDER [J].
PANSADORO, V ;
DEPAULA, F .
JOURNAL OF UROLOGY, 1987, 138 (02) :299-301
[33]  
RATLIFF TL, 1987, CANCER RES, V47, P1762
[34]   ROLE OF FIBRONECTIN IN INTRAVESICAL BCG THERAPY FOR SUPERFICIAL BLADDER-CANCER [J].
RATLIFF, TL ;
KAVOUSSI, LR ;
CATALONA, WJ .
JOURNAL OF UROLOGY, 1988, 139 (02) :410-414
[35]   REQUIREMENT OF A THYMUS DEPENDENT IMMUNE-RESPONSE FOR BCG-MEDIATED ANTITUMOR-ACTIVITY [J].
RATLIFF, TL ;
GILLEN, D ;
CATALONA, WJ .
JOURNAL OF UROLOGY, 1987, 137 (01) :155-158
[36]  
RIEDASCH G, 1981, DIALYSIS TRANSPLANT, V10, P644
[37]   CHANGES OF THE MUCOSAL ARCHITECTURE AND OF URINE CYTOLOGY DURING BCG TREATMENT [J].
SHAPIRO, A ;
LIJOVETZKY, G ;
PODE, D .
WORLD JOURNAL OF UROLOGY, 1988, 6 (01) :61-64
[38]  
VANDERMEIJDEN APM, 1986, UROL RES, V14, P207
[39]  
VANDERMEIJDEN APM, 1988, VIRCHOWS ARCH B, V55, P207
[40]  
WINTERS WD, 1981, CANCER RES, V41, P2672